Edoardo Mortato

8PUBLICATIONS
39CO-AUTHORS
AllergyPharmacogenomicsMedical biochemistry - lipidsGene and molecular therapyNanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 28, 2026
Long-Term Impact of Guselkumab on Systemic Inflammation Indices in Moderate-to-Severe Psoriasis.

Edoardo Mortato, Lorenzo Marcelli, Agostino Panichelli

|Sep 22, 2025
Long-Term Real-World Effectiveness and Drug Survival of Guselkumab in Patients with Psoriasis: A 5-Year Retrospective Study.

Edoardo Mortato, Marina Talamonti, Lorenzo Marcelli

|Jun 03, 2025
Severe paradoxical generalized pustular psoriasis induced by adalimumab biosimilar successfully treated with brodalumab.

Angela Fico, Edoardo Mortato, Claudia Paganini

|Apr 16, 2025
Effects of Guselkumab on the FIB-4 Index in Psoriasis Patients (EGIPT): A Three-Year Study.

Edoardo Mortato, Lorenzo Marcelli, Lorenzo Tofani

|Oct 26, 2024
Fast Clinical Response of Bimekizumab in Nail Psoriasis: A Retrospective Multicenter 36-Week Real-Life Study.

Elena Campione, Fabio Artosi, Ruslana Gaeta Shumak

Pageof 2